2Okamura K, Ikenoue H, Shiroozu A, et al. Reevaluation of the effects of methyl-mercaptoimidazole and propylthiouracil in patients with Gravesr hyperthyroidism[J]. J Clin Endocrinol Metab, 1987, 65(4): 719-723.
3Homsanit M, Sriussadaporn S, Vannasaeng S, et al. Efficacy of single daily dosage of methimazole vs. Propylthiouracil in the induction of euthyroidism[J]. Clin Endocrinol (Oxf), 2001, 54(3): 385-390.
4He CT, Hsieh AT, Pei D, et al. Comparison of single daily dose of methimazo|e and propylthiouracil in the treatment of Graves' hyperthyroidism[J]. Clin Endocrinol (Oxf), 2004,60 (6), 676-681.
5Nakamura H, Noh JY, Itoh K, et al. Comparison of me- thimazole and propyIthiouracil in patients with hyperthyroid- ism caused by Graves' disease[J]. J Clin Endocrinol Metab, 2007, 92(6): 2157-2162.
6Russo MW, Galanko JA, Shrestha R, et al. Liver transplan- tation for acute liver failure from drug induced liver injury in the United States[J]. Liver Transplantat, 2004,10(8) : 1018- 1023.
7Konishi T, Okamoto Y, Ueda M, et al. Drug discontinuation after treatment with minimum maintenance dose of an antithy- roid drug in Graves disease: a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission[J]. Endocrine J, 2011, 58(2) : 95-100.
8Mazza E, Carlini M, Flecchia D, et al. Long-term followup of patients with hyperthyroidism due to Gravesr disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs. continuous treatment with low methimazole doses: a retrospective study[-J]. J Endocrinol In- vest, 2008, 31(10): 866-872.
